7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 1/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 11

Drug I nformat ion ResourcesDrug I nformat ion Resources

P.K.LAKSHMIP.K.LAKSHMI

DI RECTORDI RECTOR -- DRUG I NFORMATI ON CENTERDRUG I NFORMATI ON CENTERKARNATAKA STATE PHARMACY COUNCI LKARNATAKA STATE PHARMACY COUNCI L

VI JAYANAGAR, BANGALORE, KARNATAKAVI JAYANAGAR, BANGALORE, KARNATAKA

EE--mail: sureshlakshmi6@yahoo.commail: sureshlakshmi6@yahoo.com

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 2/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 22

ObjectivesObjectives

•• Describe how the exponential growth of drug informationDescribe how the exponential growth of drug informationchallenges t he pract ice of drug informat ionchallenges the pract ice of drug inform at ion

•• Describe the at t ribut es of and the differences betw een primary,Describe t he at t ribut es of and the differences betw een pr imary,

secondary, and tert iary resourcessecondary, and t ert iary resources•• Cri t ique pr imary, secondary, and tert iary resourcesCrit ique pr imary, secondary, and tert iary resources

•• I dent ify t he most appropriate resources for a given drugI dent ify t he most appropriate resources for a given druginformat ion inquiry and use t hem effect ivelyinformation inquiry and use them effect ively

•• Recognize that primary, secondary, and tertiary resources mayRecognize that primary, secondary, and tertiary resources maybe available in hardbe available in hard-- copy, CDcopy, CD--ROM, and/ or online form atsROM, and/ or online form ats

•• Describe how to search comput erized dat abasesDescr ibe how to search comput erized databases

•• Understand the role of computer bulletin boards and theUnderstand the role of computer bulletin boards and theI nternet as drug informat ion resourcesI nt ernet as drug informat ion resources

•• Recognize that professional organizations, pharmaceuticalRecognize that professional organizations, pharmaceuticalmanufacturers, drug information centers, and poison controlmanufacturers, drug information centers, and poison controlcenters are alternate sources of drug in format ioncent ers are alternate sources of drug in format ion

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 3/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 33

Modif ied Systemat ic ApproachModif ied Syst emat ic Approach

to Drug I nformat ionto Drug I nformat ion

3. Primary literatureOriginal research reports

2. Secondary literatureIndexing and abstractingservices

1. Tertiary literatureTextbooks / drug compendia

Step-wise Approach to Using Drug Information Resources

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 4/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 44

Tert iary Lit erat ureTert iary Lit erat ure

TYPES OF TERTI ARY LI TERATURETYPES OF TERTI ARY LI TERATURE

•• TextbooksTextbooks•• CompendiaCompendia

•• Full t ext comput er databasesFull t ext comput er databases

•• Review art iclesReview art icles

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 5/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 55

Tert iary Lit erat ureTert iary Lit erature

•• AdverseAdverse EventEvent ResourcesResources•• DrugDrug Interact ionInteract ion ResourcesResources

•• Drug Use I n Renal Failure ResourcesDrug Use I n Renal Failure Resources

•• Ext emporaneous Compounding ResourcesExt emporaneous Compounding Resources

•• Foreign And Domest ic Drug I dent if icat ion ResourcesForeign And Domest ic Drug I dent if icat ion Resources

•• General Drug I nform ation ResourcesGeneral Drug I nform at ion Resources

•• Geriat r ic Dosing ResourcesGeriat r ic Dosing Resour ces

•• Medical ResourcesMedical Resources

•• Natural Product ResourcesNatural Product Resources

•• OverOver -- thethe-- count er Drug Resourcescount er Drug Resources•• Pat ient Counseling ResourcesPat ient Counseling Resources

•• Pediat r ic Dosing ResourcesPediat r ic Dosing Resour ces

•• Pharmacokinet ics ResourcesPharmacokinet ics Resources

•• Pharmacology ResourcesPharmacology Resources

•• Pharmacotherapy ResourcesPharmacotherapy Resources

•• Pharmacy Pract ice Resour cesPharmacy Pract ice Resources

•• Poison Cont rol I nform ation ResourcesPoison Cont rol I nformat ion Resources

•• Sterile Drug Product ResourcesSterile Drug Product Resources

•• Teratogenicit y ResourcesTeratogenicit y Resources•• Veterinary I nformationVeterinary I nformat ion

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 6/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 66

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 7/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 77

Secondary Lit eratureSecondary Lit erature

•• BIOSIS PreviewsBIOSIS Previews

•• Clinical Abstracts/Current Therapeutic Findings (CA/CTF)Clinical Abstracts/Current Therapeutic Findings (CA/CTF)

•• Current ContentsCurrent Contents

•• EmbaseEmbase

•• IndexIndex MedicusMedicus

•• InPharmaInPharma

•• International Pharmaceutical AbstractsInternational Pharmaceutical Abstracts

•• Iowa Drug Information System (IDIS)Iowa Drug Information System (IDIS)

•• MEDLINEMEDLINE

•• ReactionsReactions

•• Science Citation IndexScience Citation Index

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 8/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 88

SEARCHI NG COMPUTERI SEDSEARCHI NG COMPUTERI SED

DATABASESDATABASES

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 9/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 99

Evaluat ion of Review Art iclesEvaluat ion of Review Art icles

•• Were art icles included in t he review ar t icle selectedWere art icles included in t he review ar t icle selectedon the basis of obj ect ive cr it er ia?on t he basis of obj ect ive cr it er ia?

•• Did t he aut hors use a variety of resources t o ident ifyDid t he aut hors use a variety of resources to ident ify

st udies for inclusion in t he review ar t icle?studies for inclusion in t he review ar t icle?•• Was t he review art icle focused on a clear ly def inedWas t he review art icle focused on a clear ly def ined

pat ient populat ion?pat ient populat ion?

•• Did t he st udies included in t he review art icle useDid t he st udies included in t he review art icle use

valid research methods?valid research methods?•• Did t he aut hors examine reasons for dif ferences inDid t he aut hors examine reasons for dif ferences in

study resul t s and conclusions?study resul t s and conclusions?

•• Were out comes of t he st udies clinically im port ant ?Were out comes of t he st udies clinically im port ant ?•• Were st udy result s analyzed quant it at ively?Were st udy result s analyzed quant it at ively?

•• Did t he aut hors consider benef it s and r isks of t heDid t he aut hors consider benef it s and risks of t hedrug t herapy?drug t herapy?

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 10/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 1010

Primary l i t erat urePrim ary l i t erature•• American DruggistAmerican Druggist

•• American Journal of CardiologyAmerican Journal of Cardiology•• American Journ al of Healt hAmerican Journ al of Healt h --System Pharm acySystem Pharm acy

•• American Journal of Pharm aceut ical Educati onAmerican Journal of Pharm aceut ical Educati on

•• American Journal of TherapeuticsAmerican Journ al of Therapeut ics

•• Annals of I nt ernal MedicineAnnals of I nt ernal Medicine

•• The Annals of PharmacotherapyThe Annals of Pharmacotherapy

•• Archives of I nt ernal MedicineArchives of I nt ernal Medicine

•• Cancer. An I nterdisciplinary I nt ernational Journal of t he AmericCancer. An I nterdisciplinary I nt ernational Journal of t he American Cancer Societyan Cancer Society

•• ChestChest•• Clinical Drug I nvest igationClinical Drug I nvest igation

•• ClinicalClinical ImmunotherapeuticsImmunotherapeutics

•• Clinical I nfectious DiseasesClinical I nfectious Diseases

•• Clinical Pharmacokineti csClinical Pharmacokineti cs

•• Clinical Pharm acy and Therapeut icsClinical Pharm acy and Therapeut ics

•• The Consultant Pharm acistThe Consultant Pharm acist

•• Critical Care MedicineCritical Care Medicine

•• Drug I nformation JournalDrug I nformation Journal•• Drug I nvestigationDrug I nvestigation

•• V DrugsV Drugs

•• Drug SafetyDrug Safety

•• Drug TopicsDrug Topics

•• PDA Medical BulletinPDA Medical Bulletin

•• FF--DD--C Report s (" The Pink Sheet" ) ( "The Tan Sheet" )C Report s (" The Pink Sheet" ) ( "The Tan Sheet" )

•• Food and Drug Law JournalFood and Drug Law Journal

•• FormularyFormulary•• JAMA. The Journal of the American Medical AssociationJAMA. The Journal of t he Ameri can Medical Associat ion

•• Journal of t he American Pharm aceut ical AssociationJournal of t he American Pharm aceut ical Association

•• Journal of Clini cal OncologyJournal of Clini cal Oncology

•• The Journal of t he Nat ional Cancer I nstit ut eThe Journal of t he Nat ional Cancer I nstit ut e

•• Journal of Pharm acy TeachingJournal of Pharm acy Teaching

•• Journal of Social and Admini strati ve Pharm acyJournal of Social and Admini strati ve Pharm acy

•• Lippincott's Hospital PharmacyLippincott's Hospital Pharmacy

•• Morbidit y and Mortalit y Weekly ReportMorbidit y and Mortalit y Weekly Report•• The Medical Lett er on Drugs and Therapeut icsThe Medical Lett er on Drugs and Therapeut ics

•• Topics in Hospital Pharm acy ManagementTopics in Hospital Pharm acy Management

•• US PharmacistUS Pharmacist

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 11/12

7/31/2019 Essential Drugs DIC Presentation 05

http://slidepdf.com/reader/full/essential-drugs-dic-presentation-05 12/12

P. K. Lakshmi, Director, DIC,P. K. Lakshmi, Director, DIC,

KSPC, B'lore, DI Training, 11thKSPC, B'lore, DI Training, 11th --

15th Dec 200615th Dec 2006 1212

AlternateAlternate SourcesSources ofof DrugDrug Informat ionInformat ion

•• Electronic bulletin boards (EBBS)Electronic bulletin boards (EBBS)

•• Internet, list servers, and USENET NewsInternet, list servers, and USENET News•• Local and national professional organizationsLocal and national professional organizations

•• Pharmaceutical manufacturersPharmaceutical manufacturers•• Drug information and poison control centersDrug information and poison control centers